Quantcast

NW Bio granted cell production patent

Northwest Biotherapeutics Inc., of Bethesda, a biotechnology company developing personalized immune therapies for solid tumor cancers, announced that it has been issued a U.S. patent covering novel processes for manufacturing human dendritic cells.

Leave a Reply

Your email address will not be published. Required fields are marked *

*

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>

 
Scroll To Top